Build Your Comparison

Side-by-side financial analysis
VET logo
VET
PBA logo
PBA
CVE logo
CVE
CNQ logo
CNQ
SU logo
SU
JPM logo
JPM
Try popular comparisons:

Stock Comparison

VET vs PBA vs CVE vs CNQ vs SU vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VET
Vermilion Energy Inc.

Oil & Gas Exploration & Production

EnergyNYSE • CA
Market Cap$1.71B
5Y Perf.+150.0%
PBA
Pembina Pipeline Corporation

Oil & Gas Midstream

EnergyNYSE • CA
Market Cap$28.10B
5Y Perf.+93.4%
CVE
Cenovus Energy Inc.

Oil & Gas Integrated

EnergyNYSE • CA
Market Cap$53.24B
5Y Perf.+505.4%
CNQ
Canadian Natural Resources Limited

Oil & Gas Exploration & Production

EnergyNYSE • CA
Market Cap$94.49B
5Y Perf.+419.5%
SU
Suncor Energy Inc.

Oil & Gas Integrated

EnergyNYSE • CA
Market Cap$73.11B
5Y Perf.+265.4%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%

VET vs PBA vs CVE vs CNQ vs SU vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VET logoVET
PBA logoPBA
CVE logoCVE
CNQ logoCNQ
SU logoSU
JPM logoJPM
IndustryOil & Gas Exploration & ProductionOil & Gas MidstreamOil & Gas IntegratedOil & Gas Exploration & ProductionOil & Gas IntegratedBanks - Diversified
Market Cap$1.71B$28.10B$53.24B$94.49B$73.11B$896.00B
Revenue (TTM)$1.81B$7.57B$49.40B$40.74B$52.01B$280.33B
Net Income (TTM)$-814M$1.69B$4.64B$9.71B$6.33B$57.05B
Gross Margin35.9%40.5%19.6%30.8%55.5%60.0%
Operating Margin20.2%34.1%14.0%26.8%27.4%25.9%
Forward P/E11.2x16.0x6.2x7.5x6.8x14.4x
Total Debt$1.30B$13.31B$17.00B$19.71B$18.37B$942.38B
Cash & Equiv.$19M$106M$2.74B$672M$3.65B$343.34B

VET vs PBA vs CVE vs CNQ vs SU vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VET
PBA
CVE
CNQ
SU
JPM
StockJun 20Jun 26Return
Vermilion Energy In… (VET)100250.0+150.0%
Pembina Pipeline Co… (PBA)100193.4+93.4%
Cenovus Energy Inc. (CVE)100605.4+505.4%
Canadian Natural Re… (CNQ)100519.5+419.5%
Suncor Energy Inc. (SU)100365.4+265.4%
JPMorgan Chase & Co. (JPM)100341.0+241.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: VET vs PBA vs CVE vs CNQ vs SU vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CVE and CNQ are tied at the top with 3 categories each (6-stock set) — the right choice depends on your priorities. Canadian Natural Resources Limited is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. PBA also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
VET
Vermilion Energy Inc.
The Income Angle

VET lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: energy exposure
PBA
Pembina Pipeline Corporation
The Income Pick

PBA ranks third and is worth considering specifically for income & stability.

  • Dividend streak 7 yrs, beta -0.06, yield 4.5%
  • 4.5% yield, 7-year raise streak, vs JPM's 1.9%
Best for: income & stability
CVE
Cenovus Energy Inc.
The Defensive Pick

CVE carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.

  • Lower volatility, beta 0.08, Low D/E 53.8%, current ratio 1.57x
  • Beta 0.08, yield 2.0%, current ratio 1.57x
  • Lower P/E (6.2x vs 14.4x)
  • Beta 0.08 vs JPM's 0.94, lower leverage
Best for: sleep-well-at-night and defensive
CNQ
Canadian Natural Resources Limited
The Growth Play

CNQ is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 23.9%, EPS growth 81.1%, 3Y rev CAGR -3.7%
  • 286.3% 10Y total return vs JPM's 465.8%
  • 23.9% revenue growth vs VET's -15.0%
  • 23.8% margin vs VET's -44.9%
Best for: growth exposure and long-term compounding
SU
Suncor Energy Inc.
The Income Angle

Among these 6 stocks, SU doesn't own a clear edge in any measured category.

Best for: energy exposure
JPM
JPMorgan Chase & Co.
The Financial Play

JPM doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.

Best for: financial services exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCNQ logoCNQ23.9% revenue growth vs VET's -15.0%
ValueCVE logoCVELower P/E (6.2x vs 14.4x)
Quality / MarginsCNQ logoCNQ23.8% margin vs VET's -44.9%
Stability / SafetyCVE logoCVEBeta 0.08 vs JPM's 0.94, lower leverage
DividendsPBA logoPBA4.5% yield, 7-year raise streak, vs JPM's 1.9%
Momentum (1Y)CVE logoCVE+100.1% vs JPM's +21.8%
Efficiency (ROA)CNQ logoCNQ11.8% ROA vs VET's -13.8%, ROIC 10.0% vs 3.5%

VET vs PBA vs CVE vs CNQ vs SU vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Oil & Gas Stocks Theme

These companies are key players in the Oil & Gas Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
VETVermilion Energy Inc.

Segment breakdown not available.

PBAPembina Pipeline Corporation
FY 2025
Product Sales
83.1%$3.8B
Fee-For-Service
16.9%$773M
CVECenovus Energy Inc.
FY 2020
Upstream
100.0%$58M
CNQCanadian Natural Resources Limited
FY 2025
Oil And Gas1
100.0%$30.0B
SUSuncor Energy Inc.

Segment breakdown not available.

JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

VET vs PBA vs CVE vs CNQ vs SU vs JPM — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVETLAGGINGSU

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 2 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 154.6x VET's $1.8B. CNQ is the more profitable business, keeping 23.8% of every revenue dollar as net income compared to VET's -44.9%. On growth, SU holds the edge at +25.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVET logoVETVermilion Energy …PBA logoPBAPembina Pipeline …CVE logoCVECenovus Energy In…CNQ logoCNQCanadian Natural …SU logoSUSuncor Energy Inc.JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$1.8B$7.6B$49.4B$40.7B$52.0B$280.3B
EBITDAEarnings before interest/tax$1.2B$3.6B$12.4B$20.5B$21.7B$81.4B
Net IncomeAfter-tax profit-$814M$1.7B$4.6B$9.7B$6.3B$57.0B
Free Cash FlowCash after capex$301M$2.0B$4.4B$6.2B$7.2B$100.9B
Gross MarginGross profit ÷ Revenue+35.9%+40.5%+19.6%+30.8%+55.5%+60.0%
Operating MarginEBIT ÷ Revenue+20.2%+34.1%+14.0%+26.8%+27.4%+25.9%
Net MarginNet income ÷ Revenue-44.9%+22.3%+9.4%+23.8%+12.2%+20.4%
FCF MarginFCF ÷ Revenue+16.6%+26.1%+8.8%+15.2%+13.9%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year-16.4%-10.4%-12.8%-14.7%+25.1%
EPS Growth (YoY)Latest quarter vs prior year-10.9%+1.3%+78.7%-45.3%+30.1%+16.0%
JPM leads this category, winning 2 of 6 comparable metrics.

Valuation Metrics

VET leads this category, winning 5 of 6 comparable metrics.

At 12.3x trailing earnings, CNQ trades at a 52% valuation discount to PBA's 25.4x P/E. On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than JPM's 18.4x.

MetricVET logoVETVermilion Energy …PBA logoPBAPembina Pipeline …CVE logoCVECenovus Energy In…CNQ logoCNQCanadian Natural …SU logoSUSuncor Energy Inc.JPM logoJPMJPMorgan Chase & …
Market CapShares × price$1.7B$28.1B$53.2B$94.5B$73.1B$896.0B
Enterprise ValueMkt cap + debt − cash$2.6B$37.5B$63.4B$108.1B$83.6B$1.50T
Trailing P/EPrice ÷ TTM EPS-3.68x25.41x18.38x12.27x17.76x16.00x
Forward P/EPrice ÷ next-FY EPS est.11.20x15.97x6.18x7.47x6.82x14.40x
PEG RatioP/E ÷ EPS growth rate0.90x
EV / EBITDAEnterprise value multiple3.92x13.83x9.04x9.55x5.09x18.36x
Price / SalesMarket cap ÷ Revenue1.35x5.05x1.50x2.99x2.09x3.20x
Price / BookPrice ÷ Book value/share1.08x2.35x2.28x3.00x2.33x2.47x
Price / FCFMarket cap ÷ FCF7.32x15.79x21.86x15.69x14.77x8.88x
VET leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

CNQ leads this category, winning 4 of 9 comparable metrics.

CNQ delivers a 24.6% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $-34 for VET. SU carries lower financial leverage with a 0.41x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CNQ scores 8/9 vs VET's 3/9, reflecting strong financial health.

MetricVET logoVETVermilion Energy …PBA logoPBAPembina Pipeline …CVE logoCVECenovus Energy In…CNQ logoCNQCanadian Natural …SU logoSUSuncor Energy Inc.JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-33.7%+10.0%+15.2%+24.6%+14.0%+15.9%
ROA (TTM)Return on assets-13.8%+4.7%+7.8%+11.8%+7.0%+1.3%
ROICReturn on invested capital+3.5%+6.9%+7.9%+10.0%+20.1%+4.5%
ROCEReturn on capital employed+3.3%+8.4%+8.2%+10.3%+19.5%+8.9%
Piotroski ScoreFundamental quality 0–9356865
Debt / EquityFinancial leverage0.59x0.79x0.54x0.44x0.41x2.60x
Net DebtTotal debt minus cash$1.3B$13.2B$14.3B$19.0B$14.7B$599.0B
Cash & Equiv.Liquid assets$19M$106M$2.7B$672M$3.6B$343.3B
Total DebtShort + long-term debt$1.3B$13.3B$17.0B$19.7B$18.4B$942.4B
Interest CoverageEBIT ÷ Interest expense2.53x4.44x11.80x14.97x11.68x0.74x
CNQ leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CVE and JPM each lead in 3 of 6 comparable metrics.

A $10,000 investment in CVE five years ago would be worth $30,275 today (with dividends reinvested), compared to $14,136 for VET. Over the past 12 months, CVE leads with a +100.1% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs VET's 1.3% — a key indicator of consistent wealth creation.

MetricVET logoVETVermilion Energy …PBA logoPBAPembina Pipeline …CVE logoCVECenovus Energy In…CNQ logoCNQCanadian Natural …SU logoSUSuncor Energy Inc.JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+31.7%+26.7%+62.1%+33.3%+37.0%-0.5%
1-Year ReturnPast 12 months+45.6%+32.5%+100.1%+42.0%+62.0%+21.8%
3-Year ReturnCumulative with dividends+4.0%+73.5%+79.1%+81.8%+123.7%+138.2%
5-Year ReturnCumulative with dividends+41.4%+74.7%+202.8%+181.1%+174.3%+118.2%
10-Year ReturnCumulative with dividends-39.7%+114.2%+109.7%+286.3%+176.8%+465.8%
CAGR (3Y)Annualised 3-year return+1.3%+20.2%+21.4%+22.1%+30.8%+33.6%
Evenly matched — CVE and JPM each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — VET and PBA each lead in 1 of 2 comparable metrics.

VET is the less volatile stock with a -0.18 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PBA currently trades 96.5% from its 52-week high vs VET's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVET logoVETVermilion Energy …PBA logoPBAPembina Pipeline …CVE logoCVECenovus Energy In…CNQ logoCNQCanadian Natural …SU logoSUSuncor Energy Inc.JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 500-0.18x-0.06x0.08x-0.15x-0.14x0.94x
52-Week HighHighest price in past year$14.82$50.10$32.07$51.34$70.29$337.25
52-Week LowLowest price in past year$7.00$35.45$13.47$29.30$37.23$262.71
% of 52W HighCurrent price vs 52-week peak+75.2%+96.5%+88.2%+88.2%+87.6%+95.1%
RSI (14)Momentum oscillator 0–10040.956.948.844.741.059.1
Avg Volume (50D)Average daily shares traded1.3M949K7.9M7.8M3.4M7.0M
Evenly matched — VET and PBA each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PBA and JPM each lead in 1 of 2 comparable metrics.

Analyst consensus: VET as "Hold", PBA as "Buy", CVE as "Hold", CNQ as "Buy", SU as "Buy", JPM as "Buy". Consensus price targets imply 15.3% upside for SU (target: $71) vs -22.7% for CNQ (target: $35). For income investors, PBA offers the higher dividend yield at 4.50% vs JPM's 1.86%.

MetricVET logoVETVermilion Energy …PBA logoPBAPembina Pipeline …CVE logoCVECenovus Energy In…CNQ logoCNQCanadian Natural …SU logoSUSuncor Energy Inc.JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellHoldBuyHoldBuyBuyBuy
Price TargetConsensus 12-month target$10.74$38.76$29.00$35.00$71.00$339.75
# AnalystsCovering analysts101627373161
Dividend YieldAnnual dividend ÷ price+4.1%+4.5%+2.0%+3.7%+2.7%+1.9%
Dividend StreakConsecutive years of raises375101015
Dividend / ShareAnnual DPS$0.64$3.04$0.78$2.32$2.30$5.95
Buyback YieldShare repurchases ÷ mkt cap+1.5%0.0%+3.4%+1.1%+3.1%+3.9%
Evenly matched — PBA and JPM each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 1 of 6 categories (Income & Cash Flow). VET leads in 1 (Valuation Metrics). 3 tied.

Best OverallVermilion Energy Inc. (VET)Leads 1 of 6 categories
Loading custom metrics...

VET vs PBA vs CVE vs CNQ vs SU vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VET or PBA or CVE or CNQ or SU or JPM a better buy right now?

For growth investors, Canadian Natural Resources Limited (CNQ) is the stronger pick with 23.

9% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). Canadian Natural Resources Limited (CNQ) offers the better valuation at 12. 3x trailing P/E (7. 5x forward), making it the more compelling value choice. Analysts rate Pembina Pipeline Corporation (PBA) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VET or PBA or CVE or CNQ or SU or JPM?

On trailing P/E, Canadian Natural Resources Limited (CNQ) is the cheapest at 12.

3x versus Pembina Pipeline Corporation at 25. 4x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 6. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — VET or PBA or CVE or CNQ or SU or JPM?

Over the past 5 years, Cenovus Energy Inc.

(CVE) delivered a total return of +202. 8%, compared to +41. 4% for Vermilion Energy Inc. (VET). Over 10 years, the gap is even starker: JPM returned +465. 8% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VET or PBA or CVE or CNQ or SU or JPM?

By beta (market sensitivity over 5 years), Vermilion Energy Inc.

(VET) is the lower-risk stock at -0. 18β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -617% more volatile than VET relative to the S&P 500. On balance sheet safety, Suncor Energy Inc. (SU) carries a lower debt/equity ratio of 41% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VET or PBA or CVE or CNQ or SU or JPM?

By revenue growth (latest reported year), Canadian Natural Resources Limited (CNQ) is pulling ahead at 23.

9% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: Canadian Natural Resources Limited grew EPS 81. 1% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, CNQ leads at -3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VET or PBA or CVE or CNQ or SU or JPM?

Canadian Natural Resources Limited (CNQ) is the more profitable company, earning 24.

5% net margin versus -37. 0% for Vermilion Energy Inc. — meaning it keeps 24. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBA leads at 36. 1% versus 8. 8% for CVE. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VET or PBA or CVE or CNQ or SU or JPM more undervalued right now?

On forward earnings alone, Cenovus Energy Inc.

(CVE) trades at 6. 2x forward P/E versus 16. 0x for Pembina Pipeline Corporation — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SU: 15. 3% to $71. 00.

08

Which pays a better dividend — VET or PBA or CVE or CNQ or SU or JPM?

All stocks in this comparison pay dividends.

Pembina Pipeline Corporation (PBA) offers the highest yield at 4. 5%, versus 1. 9% for JPMorgan Chase & Co. (JPM).

09

Is VET or PBA or CVE or CNQ or SU or JPM better for a retirement portfolio?

For long-horizon retirement investors, Canadian Natural Resources Limited (CNQ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

15), 3. 7% yield, +286. 3% 10Y return). Both have compounded well over 10 years (CNQ: +286. 3%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VET and PBA and CVE and CNQ and SU and JPM?

These companies operate in different sectors (VET (Energy) and PBA (Energy) and CVE (Energy) and CNQ (Energy) and SU (Energy) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VET is a small-cap income-oriented stock; PBA is a mid-cap income-oriented stock; CVE is a mid-cap quality compounder stock; CNQ is a mid-cap high-growth stock; SU is a mid-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.